Form 8-K - Current report:
SEC Accession No. 0001437749-26-010409
Filing Date
2026-03-31
Accepted
2026-03-30 18:40:24
Documents
14
Period of Report
2026-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20260330_8k.htm   iXBRL 8-K 34050
2 EXHIBIT 99.1 ex_939162.htm EX-99.1 189531
7 diamedicalogo.jpg GRAPHIC 6910
  Complete submission text file 0001437749-26-010409.txt   375024

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20260330.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20260330_def.xml EX-101.DEF 11030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20260330_lab.xml EX-101.LAB 14743
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20260330_pre.xml EX-101.PRE 11135
18 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20260330_8k_htm.xml XML 2742
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 26815790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)